GB1299201A - Medicaments derived from thiazolidine carboxylic acid - Google Patents

Medicaments derived from thiazolidine carboxylic acid

Info

Publication number
GB1299201A
GB1299201A GB63488/69A GB6348869A GB1299201A GB 1299201 A GB1299201 A GB 1299201A GB 63488/69 A GB63488/69 A GB 63488/69A GB 6348869 A GB6348869 A GB 6348869A GB 1299201 A GB1299201 A GB 1299201A
Authority
GB
United Kingdom
Prior art keywords
carboxylic acid
dec
thiazolidine carboxylic
medicaments
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB63488/69A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sogespar SA
Original Assignee
Sogespar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sogespar SA filed Critical Sogespar SA
Publication of GB1299201A publication Critical patent/GB1299201A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

1299201 Thiazolidine derivatives SOGESPAR SA 31 Dec 1969 [31 Dec 1968] 63488/69 Heading C2C Novel compounds of general Formula I in which R 1 is H, CH 3 or C 2 H 5 ; R 2 is alkoxy, morpholino or amino which may be substituted by one or two alkyl groups and R 3 is H or alkyl are prepared by esterification of the appropriate acid followed if desired by conventional amide formation from the ester. Pharmaceutical compositions for enteral, parenteral, or topical administration in treatment of diseases of the mucous membrane comprise a compound I together with a suitable diluent or carrier.
GB63488/69A 1968-12-31 1969-12-31 Medicaments derived from thiazolidine carboxylic acid Expired GB1299201A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR182571A FR8266M (en) 1968-12-31 1968-12-31

Publications (1)

Publication Number Publication Date
GB1299201A true GB1299201A (en) 1972-12-13

Family

ID=8659685

Family Applications (1)

Application Number Title Priority Date Filing Date
GB63488/69A Expired GB1299201A (en) 1968-12-31 1969-12-31 Medicaments derived from thiazolidine carboxylic acid

Country Status (7)

Country Link
BE (1) BE743905A (en)
CA (1) CA959850A (en)
CH (1) CH511248A (en)
DE (1) DE1965343A1 (en)
ES (1) ES375023A1 (en)
FR (1) FR8266M (en)
GB (1) GB1299201A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592905A (en) * 1969-10-30 1971-07-13 Merck & Co Inc Therapeutic methods
FR2222087B1 (en) * 1973-03-22 1976-04-09 Ferlux
IT1190945B (en) * 1982-08-06 1988-02-24 Salus Research Sarm Spa COMPOUND WITH BRONCHO-SECRETOGOGUE, FLUIDIFYING AND ANTITUSSIGENIC ACTION, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DE3376341D1 (en) * 1982-08-09 1988-05-26 Ajinomoto Kk Method for producing 2-substituted-thiazolidine-4-carboxylic acids
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
ES2034041T3 (en) * 1988-06-29 1993-04-01 Yason S.R.L N-CARBOTOXI-4-THIAZOLIDIN-CARBOXYLIC ACID, PROCESS FOR ITS PREPARATION AND USE AS A MEDICINAL PRODUCT.

Also Published As

Publication number Publication date
CA959850A (en) 1974-12-24
FR8266M (en) 1970-10-26
ES375023A1 (en) 1972-03-01
CH511248A (en) 1971-08-15
DE1965343A1 (en) 1970-07-23
BE743905A (en) 1970-05-28

Similar Documents

Publication Publication Date Title
GB1432576A (en) Substituted phenylacetic acids
GB1331405A (en) Esters their production and their medicinal use
GB1213162A (en) Serum lipid lowering pyridine derivatives and their preparation
GB1322988A (en) Thiaheterocyclyl-acetic acid derivatives
GB1358624A (en) Phenylacetic acid derivatives process for their preparation and applications thereof
GB1299201A (en) Medicaments derived from thiazolidine carboxylic acid
GB1178658A (en) Indene Derivatives and Production thereof
GB1131498A (en) Niconitic acid esters
GB1471910A (en) Lysine salt
GB1390867A (en) Quinoline derivatives
GB1496491A (en) Dihydroergopeptine derivatives
GB1322987A (en) On,n-diacylhydroxylamine derivatives and preparation
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
GB1263116A (en) Chloramphenicol and thiamphenicol derivatives
GB1448758A (en) Thiazole derivatives
GB1276359A (en) Anthranilic acid derivatives
GB1252248A (en)
GB1322069A (en) Aminoalkanoylaminocyclohexane derivatives
GB1504683A (en) Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives
GB1335403A (en) Pharmaceutical compositions containing benzofuran derivatives
GB1374281A (en) Thiazolino-pyrimidin-5-one derivatives process for their pre paration and applications thereof
GB1369888A (en) Substituted amidines
GB1434645A (en) Tetrazole coumarin derivatives
GB1378419A (en) Phenylalanine derivatives
GB1355689A (en) Piperidylfuranones

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee